BioCentury
ARTICLE | Company News

Abgenix and Dyax in antibody technology deal

January 8, 2001 8:00 AM UTC

The companies will combine ABGX's XenoMouse technology with DYAX's phage display technology to develop libraries of XenoMouse-derived antibodies for multiple therapeutic targets. The companies will sh...